Reported 1 day ago
Vericel Corporation (VCEL) is highlighted as a compelling investment opportunity based on its transition into a profitable leader in regenerative medicine, marked by significant growth in sports and burn care markets. With strong revenue growth, an expanding surgeon base, and a debt-free balance sheet, VCEL is poised for continued success. Current valuations suggest a price target significantly above its trading value, making it an attractive option for investors looking for a resilient growth story.
Source: YAHOO